Skip to main content
OpenTrials
Completed

NCT Number: NCT04980157

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

The purpose of the study is to examine the efficacy of educational materials to promote hepatitis C virus (HCV) screening and colorectal cancer (CRC) screening uptake among adults born between 1945-1965.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C Virus Infection Blood-Borne Infections Colonic Diseases Colorectal Cancer Colorectal Neoplasms Communicable Diseases Digestive System Diseases Digestive System Neoplasms Flaviviridae Infections Gastrointestinal Diseases Gastrointestinal Neoplasms Hepatitis Hepatitis C Hepatitis, Viral, Human Infections Intestinal Diseases Intestinal Neoplasms Liver Diseases Neoplasms Neoplasms by Site RNA Virus Infections Rectal Diseases Virus Diseases

Age range

56 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Moffitt Cancer Center

Tampa, Florida, 33612, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Born between 1945 and 1965 and up to age 75
  • No personal history of colorectal cancer (CRC) or current presumptive colorectal cancer symptoms (e.g., unresolved rectal bleeding or abdominal pain/bloating)
  • No personal history of hepatitis C virus (HCV) or liver cancer
  • Able to read, write, speak, and understand English or Spanish
  • Not currently enrolled in another CRC screening or a HCV screening study
  • At average risk for CRC (that is, no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC)
  • Not currently up-to date with CRC screenings
  • Not having previously completed HCV screening
  • Able and willing to complete a phone interview
  • Able to provide informed consent

Treatment and study plan

CARES-HCV

Behavioral

CARES-HCV is an educational intervention to promote both hepatitis c screening and colorectal cancer screening among diverse baby boomers in the area.

Primary outcomes

  1. Change in Hepatitis C Virus (HCV) knowledge

    Time frame: Day 1 & Day 7

    Participants will be interviewed regarding their HCV knowledge on Day 1 prior to receiving educational materials. They will be interviewed once again approximately one week after receiving educational materials.

  2. Change in Colorectal Cancer (CRC) knowledge

    Time frame: Day 1 & Day 7

    Participants will be interviewed regarding their CRC knowledge on Day 1 prior to receiving educational materials. They will be interviewed once again approximately one week after receiving educational materials.

  3. Hepatitis C Virus Screening Status

    Time frame: at 6 months

    Data about participants' HCV screening status will be collected from Federally Qualified Health Care Center's (FQHC) 6 months after participants have received educational materials.

  4. Colorectal Cancer Screening Status

    Time frame: at 6 months

    Data about participants' CRC screening status will be collected from Federally Qualified Health Care Center's (FQHC) 6 months after participants have received educational materials.

Sponsors and collaborators

Lead sponsor

H. Lee Moffitt Cancer Center and Research Institute

Other

Registry information

Official study title

CARES-HCV: Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jul 28, 2021
Registry last updated
Jan 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.